Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. PHR
stocks logo

PHR

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q3
FY2026Q4
FY2027Q1
120.03M
+12.39%
0.003
-101.12%
132.36M
+20.68%
-0.040
-63.64%
137.16M
+18.31%
0.120
-271.43%
Estimates Revision
The market is revising Upward the revenue expectations for Phreesia, Inc. (PHR) for FY2026, with the revenue forecasts being adjusted by 1.98% over the past three months. During the same period, the stock price has changed by -26.95%.
Revenue Estimates for FY2026
Revise Upward
up Image
+1.98%
In Past 3 Month
EPS Estimates for FY2026
Revise Downward
down Image
-51.89%
In Past 3 Month
Stock Price
Go Down
down Image
-26.95%
In Past 3 Month
Wall Street analysts forecast PHR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PHR is 34.10 USD with a low forecast of 32.00 USD and a high forecast of 38.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
Wall Street analysts forecast PHR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PHR is 34.10 USD with a low forecast of 32.00 USD and a high forecast of 38.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Buy
0 Hold
0 Sell
Strong Buy
Current: 20.550
sliders
Low
32.00
Averages
34.10
High
38.00
Current: 20.550
sliders
Low
32.00
Averages
34.10
High
38.00
DA Davidson
Clark Wright
Buy
maintain
$33 -> $35
2025-12-02
New
Reason
DA Davidson
Clark Wright
Price Target
$33 -> $35
2025-12-02
New
maintain
Buy
Reason
DA Davidson analyst Clark Wright raised the firm's price target on Phreesia to $35 from $33 and keeps a Buy rating on the shares after its completed AccessOne acquisition. The asset represents a key growth lever to unlock incremental revenue opportunities with new and existing customers, the analyst tells investors in a research note. Phreesia shares have also underperformed since the company reported Q2 results, down 36% vs. the IGV ETF, which is down 3%, the firm added.
BMO Capital
Sean Dodge
Outperform
initiated
$32
2025-11-12
Reason
BMO Capital
Sean Dodge
Price Target
$32
2025-11-12
initiated
Outperform
Reason
BMO Capital analyst Sean Dodge initiated coverage of Phreesia with an Outperform rating and $32 price target. The is gaining traction with cross-selling efforts while the pending AccessOne acquisition adds more growth in the long term, the analyst tells investors in a research note. The firm sees Phreesia's "significant" operating leverage driving high-20s to low-30s EBITDA growth over the next few years.
Citizens JMP
Aaron Kimson
Outperform
maintain
$30 -> $34
2025-09-08
Reason
Citizens JMP
Aaron Kimson
Price Target
$30 -> $34
2025-09-08
maintain
Outperform
Reason
Citizens JMP analyst Aaron Kimson raised the firm's price target on Phreesia to $34 from $30 and keeps an Outperform rating on the shares. Phreesia announced better than expected Q2 results and the acquisition of AccessOne for $160M, the analyst tells investors in a research note. The firm believes the AccessOne acquisition is a logical strategic fit that will help Phreesia expand its existing payments business, and thinks the acquisition should be accretive to adjusted EBITDA margins once closed.
Piper Sandler
Overweight
maintain
$33 -> $34
2025-09-05
Reason
Piper Sandler
Price Target
$33 -> $34
2025-09-05
maintain
Overweight
Reason
Piper Sandler raised the firm's price target on Phreesia to $34 from $33 and keeps an Overweight rating on the shares.The firm thinks the AccessOne acquisition and VoiceAI product launch set Phreesia up for a series of positive revisions to guidance and consensus estimates over the next 12-24 months.
Canaccord
Richard Close
NULL -> Buy
maintain
$34 -> $38
2025-09-05
Reason
Canaccord
Richard Close
Price Target
$34 -> $38
2025-09-05
maintain
NULL -> Buy
Reason
Canaccord analyst Richard Close raised the firm's price target on Phreesia to $38 from $34 and keeps a Buy rating on the shares. The firm said the Q2 report was a beat on revenues as predicted but coming out of the report the cmpany announced three new products in VoiceAI, AI-Assisted Referrals, and Out-of-Network Tags as well as the acquisition of AccessOne for $160 million.
DA Davidson
Buy
initiated
$33
2025-09-05
Reason
DA Davidson
Price Target
$33
2025-09-05
initiated
Buy
Reason
DA Davidson assumed coverage of Phreesia with a Buy rating and $33 price target. The firm believes Phreesia has the ability to address a broader scope of problems on behalf of providers, patients, and pharma companies, which it argues should translate to durable double-digit growth and ongoing margin expansion.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Phreesia Inc (PHR.N) is 78.20, compared to its 5-year average forward P/E of -35.44. For a more detailed relative valuation and DCF analysis to assess Phreesia Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-35.44
Current PE
78.20
Overvalued PE
93.42
Undervalued PE
-164.30

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-38.18
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
84.40
Undervalued EV/EBITDA
-160.76

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
5.90
Current PS
0.00
Overvalued PS
10.35
Undervalued PS
1.46
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

PHR News & Events

Events Timeline

(ET)
2025-09-04
16:24:42
Phreesia confirms FY26 revenue outlook of $472M-$482M, in line with consensus of $476.7M
select
2025-09-04
16:23:39
Phreesia announces Q2 adjusted EBITDA of $22.1M, up from $6.5M a year ago.
select
2025-09-04
16:03:51
Phreesia to purchase AccessOne for $160 million
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
5.0
05:12 AMNewsfilter
Phreesia's Megan Turco Named to MM+M's 2025 40 Under 40 List
  • Leadership Recognition: Phreesia's Director of Client Experience, Megan Turco, has been named to MM+M's 2025 40 Under 40 list, highlighting her creativity and leadership in healthcare marketing, which enhances the company's reputation in the industry.
  • Team Expansion: Since joining in 2018, Turco has grown the Client Experience team from four to over 50 professionals, driving success in strategy, execution, and growth for more than 80 life sciences and agency clients, showcasing her exceptional team-building skills.
  • Performance Growth: Under Turco's leadership, the sales team has exceeded targets for four consecutive years, achieving double-digit annual revenue growth, indicating her strategic execution and market adaptability, which have brought significant economic benefits to the company.
  • Customer Satisfaction Improvement: Internal survey data reveals that 95% of clients rate their Client Experience representative as
[object Object]
Preview
9.5
11-21NASDAQ.COM
Veeva Systems (VEEV) Exceeds Q3 Earnings and Revenue Projections

  • Earnings Performance: Veeva Systems reported quarterly earnings of $2.04 per share, exceeding the Zacks Consensus Estimate of $1.95, and showing a year-over-year increase from $1.75 per share. The company has consistently surpassed earnings expectations over the last four quarters.

  • Revenue Growth: The company generated revenues of $811.24 million for the quarter, surpassing the Zacks Consensus Estimate by 2.44% and reflecting a significant increase from $699.21 million in the previous year.

  • Stock Outlook: Veeva shares have risen approximately 29.8% year-to-date, outperforming the S&P 500's 12.9% gain. The stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.

  • Industry Context: The Medical Info Systems industry, to which Veeva belongs, is ranked in the top 29% of Zacks industries, suggesting a favorable outlook. Meanwhile, Phreesia, another company in the same sector, is set to report its earnings soon, with positive expectations.

[object Object]
Preview
3.0
11-20Yahoo Finance
Assessing Phreesia (PHR): Is There Potential for Value Following the Recent Decline?

  • Phreesia's Stock Performance: Phreesia (PHR) shares have declined approximately 2% recently, with a notable 17% drop over the past week, despite a modest gain in total shareholder return over the last year.

  • Valuation and Future Prospects: The stock's last close at $19.19 is significantly below the analyst target of $33.73, indicating potential upside, but investors are questioning whether the stock is undervalued or if future prospects are already priced in.

  • Growth Drivers: The company's expansion of value-added modules is expected to increase recurring revenue and enhance net margins, supporting top-line growth and a larger market share in healthcare.

  • Risks and Considerations: Investors should be aware of ongoing competition and regulatory changes that may impact Phreesia's growth trajectory, and it's crucial to monitor execution risks closely.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Phreesia Inc (PHR) stock price today?

The current price of PHR is 20.55 USD — it has increased 0.83 % in the last trading day.

arrow icon

What is Phreesia Inc (PHR)'s business?

Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.

arrow icon

What is the price predicton of PHR Stock?

Wall Street analysts forecast PHR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PHR is 34.10 USD with a low forecast of 32.00 USD and a high forecast of 38.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Phreesia Inc (PHR)'s revenue for the last quarter?

Phreesia Inc revenue for the last quarter amounts to 117.26M USD, increased 14.83 % YoY.

arrow icon

What is Phreesia Inc (PHR)'s earnings per share (EPS) for the last quarter?

Phreesia Inc. EPS for the last quarter amounts to 0.01 USD, decreased -103.23 % YoY.

arrow icon

What changes have occurred in the market's expectations for Phreesia Inc (PHR)'s fundamentals?

The market is revising Upward the revenue expectations for Phreesia, Inc. (PHR) for FY2026, with the revenue forecasts being adjusted by 1.98% over the past three months. During the same period, the stock price has changed by -26.95%.
arrow icon

How many employees does Phreesia Inc (PHR). have?

Phreesia Inc (PHR) has 2082 emplpoyees as of December 05 2025.

arrow icon

What is Phreesia Inc (PHR) market cap?

Today PHR has the market capitalization of 1.23B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free